Physician

Guangzhi Qu, M.D.

According to 2025 Medicare claims, Guangzhi Qu, M.D. (NPI: 1790780716) practices hematology/oncology in the Jackson, MS market, with the plurality of this provider's patient population coming from Rankin, MS. This provider's primary affiliated billing organization is JACKSON ONCOLOGY ASSOCIATES (NPI: 1295776136; TIN: 640619700) and primary practice location at 39216-4121. Qu is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645) and Ochsner Senior Care Network, LLC (ACO ID: A5662), participating under the MSSP model.

Qu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,208 traditional Medicare patients, billed 647,096 HCPCS/CPT codes, and received $12,351,361 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,813 prescription claims across 480 beneficiaries totaling $8,826,665 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 35 claims. Open Payments data shows 119 records totaling $3,017. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $4,654,463 to $12,351,361. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,320,405 to $8,826,665. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $20,664 to $593.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$6.9M$14M2015 Medicare payment: $4,654,463 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $5,816,777 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $6,791,676 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $6,831,822 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $8,124,868 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $9,291,501 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $9,660,388 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $10,968,791 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $13,712,096 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $12,351,361 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015895505,834$4,654,463
2016984440,507$5,816,777
20171,102585,729$6,791,676
20181,135517,957$6,831,822
20191,105559,902$8,124,868
20201,129647,814$9,291,501
20211,121811,885$9,660,388
20221,085812,581$10,968,791
20231,242801,310$13,712,096
20241,208647,096$12,351,361

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.2M$10M2015 Drug cost: $2,320,405 (USD; Tot_Drug_Cst)2016 Drug cost: $3,508,221 (USD; Tot_Drug_Cst)2017 Drug cost: $3,583,246 (USD; Tot_Drug_Cst)2018 Drug cost: $5,203,014 (USD; Tot_Drug_Cst)2019 Drug cost: $5,180,181 (USD; Tot_Drug_Cst)2020 Drug cost: $7,715,444 (USD; Tot_Drug_Cst)2021 Drug cost: $10,445,112 (USD; Tot_Drug_Cst)2022 Drug cost: $10,309,808 (USD; Tot_Drug_Cst)2023 Drug cost: $9,913,974 (USD; Tot_Drug_Cst)2024 Drug cost: $8,826,665 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153301,937$2,320,405
20163432,260$3,508,221
20173612,316$3,583,246
20183892,363$5,203,014
20193902,239$5,180,181
20203672,469$7,715,444
20213972,808$10,445,112
20223992,423$10,309,808
20234162,403$9,913,974
20244802,813$8,826,665

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$11K$21K2015 Medicare payment: $21,470 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $9,082 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $827 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $687 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $6,988 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,038 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201559299$21,470
201639163$9,082
2017N/RN/RN/R
2018N/R23$827
2019N/RN/RN/R
2020N/R13$687
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R26$6,988
2024N/R35$1,038

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more8061,718$92
82728Ferritin (blood protein) level5981,040$13
80053Blood test, comprehensive group of blood chemicals9703,954$10
36415Insertion of needle into vein for collection of blood sample8843,133$8
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count9904,692$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide531,484$1,169,420
NinlaroIxazomib Citrate571,596$693,695
VerzenioAbemaciclib471,316$678,955
LenalidomideLenalidomide471,316$674,335
XpovioSelinexor23644$672,447

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R19$737
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R16$301

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.119$3,017GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Guangzhi Qu, M.D.?

Tedicare shows public-source Medicare data for Guangzhi Qu, M.D. (NPI 1790780716), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Guangzhi Qu, M.D. have ACO affiliation data?

Guangzhi Qu, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645) and Ochsner Senior Care Network, LLC (MSSP, ACO ID A5662).

What billing organization is linked to Guangzhi Qu, M.D.?

Guangzhi Qu, M.D. is linked to JACKSON ONCOLOGY ASSOCIATES (billing NPI 1295776136) in the available physician profile data.

Does Guangzhi Qu, M.D. have Open Payments data?

Guangzhi Qu, M.D. has 119 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.